(R)-3-((1-Aminocyclopropyl)methyl)-8-(6-methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one

ID: ALA4513589

PubChem CID: 155538969

Max Phase: Preclinical

Molecular Formula: C23H26N6O2

Molecular Weight: 418.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(N)CC5)c(NC5(C)CC5)nc34)[nH]c21

Standard InChI:  InChI=1S/C23H26N6O2/c1-12-17-15(19(30)25-12)10-16(26-17)13-4-3-5-14-18(13)27-21(28-22(2)6-7-22)29(20(14)31)11-23(24)8-9-23/h3-5,10,12,26H,6-9,11,24H2,1-2H3,(H,25,30)(H,27,28)/t12-/m1/s1

Standard InChI Key:  MDSSZYNUYNBVFZ-GFCCVEGCSA-N

Molfile:  

 
     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
   13.3970  -19.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8097  -20.1285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2181  -19.4161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0413  -22.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6369  -21.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2279  -22.4619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2253  -19.3113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2253  -20.1285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9306  -20.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6359  -20.1285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9306  -18.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6335  -19.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3407  -18.9097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3462  -18.0946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6386  -17.6832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9343  -18.0877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0493  -19.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1293  -20.1343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7980  -18.9937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3408  -19.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9308  -20.3114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4764  -20.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2237  -20.5889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1398  -19.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3050  -21.7188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7481  -19.2304    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5164  -18.9048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.9306  -21.3502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3460  -21.3502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5182  -20.5381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1028  -20.5402    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  5  4  1  0
  6  5  1  0
  4  6  1  0
  7  8  1  0
  7 11  1  0
  8  9  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  1  0
 18 21  1  0
 20 19  1  0
 19 17  2  0
 13 17  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 22 25  1  6
 24 26  2  0
  7 27  2  0
  9 28  1  0
 28  5  1  0
  5 29  1  0
  8 30  1  0
 30  2  1  0
  2 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4513589

    ---

Associated Targets(Human)

PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM2 Tchem Serine/threonine-protein kinase PIM2 (5873 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.50Molecular Weight (Monoisotopic): 418.2117AlogP: 2.65#Rotatable Bonds: 5
Polar Surface Area: 117.83Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 10.98CX Basic pKa: 8.64CX LogP: 1.15CX LogD: -0.12
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.01

References

1. Wang HL, Andrews KL, Booker SK, Canon J, Cee VJ, Chavez F, Chen Y, Eastwood H, Guerrero N, Herberich B, Hickman D, Lanman BA, Laszlo J, Lee MR, Lipford JR, Mattson B, Mohr C, Nguyen Y, Norman MH, Pettus LH, Powers D, Reed AB, Rex K, Sastri C, Tamayo N, Wang P, Winston JT, Wu B, Wu Q, Wu T, Wurz RP, Xu Y, Zhou Y, Tasker AS..  (2019)  Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies.,  62  (3): [PMID:30624936] [10.1021/acs.jmedchem.8b01733]

Source